{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:29:25Z","timestamp":1793039365341,"version":"4.5.0"},"reference-count":297,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T00:00:00Z","timestamp":1719705600000},"content-version":"am","delay-in-days":334,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA044999"],"award-info":[{"award-number":["DA044999"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.bcp.2023.115665","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T02:00:25Z","timestamp":1687226425000},"page":"115665","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Mechanisms of cannabinoid tolerance"],"prefix":"10.1016","volume":"214","author":[{"given":"Mary K.","family":"Piscura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela N.","family":"Henderson-Redmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swarup","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9e","family":"Guindon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9467-4019","authenticated-orcid":false,"given":"Daniel J.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2023.115665_b0005","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0091-3057(93)90546-6","article-title":"Development of behavioral tolerance to delta 9-THC without alteration of cannabinoid receptor binding or mRNA levels in whole brain","volume":"46","author":"Abood","year":"1993","journal-title":"Pharmacol Biochem Behav"},{"issue":"7","key":"10.1016\/j.bcp.2023.115665_b0010","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/s41386-019-0585-3","article-title":"Orally consumed cannabinoids provide long-lasting relief of allodynia in a mouse model of chronic neuropathic pain","volume":"45","author":"Abraham","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"1-3","key":"10.1016\/j.bcp.2023.115665_b0015","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0014-2999(95)00447-S","article-title":"Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A","volume":"282","author":"Aceto","year":"1995","journal-title":"Eur J Pharmacol"},{"issue":"1-2","key":"10.1016\/j.bcp.2023.115665_b0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0014-2999(01)00873-1","article-title":"Spontaneous and precipitated withdrawal with a synthetic cannabinoid, WIN 55212\u20132","volume":"416","author":"Aceto","year":"2001","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.bcp.2023.115665_b0025","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0306-4522(00)00389-4","article-title":"Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons","volume":"100","author":"Ahluwalia","year":"2000","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.bcp.2023.115665_b0030","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.bmcl.2013.12.119","article-title":"Predicting the molecular interactions of CRIP1a-cannabinoid 1 receptor with integrated molecular modeling approaches","volume":"24","author":"Ahmed","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bcp.2023.115665_b0035","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3389\/fphar.2020.00628","article-title":"Advances in Neurobiology and Pharmacology of GPR12","volume":"11","author":"Allende","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bcp.2023.115665_b0040","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"issue":"1","key":"10.1016\/j.bcp.2023.115665_b0045","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/02791072.2010.10399782","article-title":"Sex differences in the effects of marijuana on simulated driving performance","volume":"42","author":"Anderson","year":"2010","journal-title":"J Psychoactive Drugs"},{"key":"10.1016\/j.bcp.2023.115665_b0050","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.neuropharm.2017.10.017","article-title":"Intoxication from the novel synthetic cannabinoids AB-PINACA and ADB-PINACA: A case series and review of the literature","volume":"134","author":"Armenian","year":"2018","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.bcp.2023.115665_b0055","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.neuropharm.2012.04.024","article-title":"CB(2) cannabinoid receptors inhibit synaptic transmission when expressed in cultured autaptic neurons","volume":"63","author":"Atwood","year":"2012","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.bcp.2023.115665_b0060","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1124\/mol.111.074013","article-title":"Functional selectivity in CB(2) cannabinoid receptor signaling and regulation: implications for the therapeutic potential of CB(2) ligands","volume":"81","author":"Atwood","year":"2012","journal-title":"Mol Pharmacol"},{"issue":"11","key":"10.1016\/j.bcp.2023.115665_b0065","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/0028-3908(94)90050-7","article-title":"Nitric oxide and opioid tolerance","volume":"33","author":"Babey","year":"1994","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.bcp.2023.115665_b0070","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.pbb.2005.11.006","article-title":"The effect of cyclosporine on the development and expression of cannabinoid tolerance in mice","volume":"82","author":"Banafshe","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bcp.2023.115665_b0075","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0376-8716(99)00150-7","article-title":"Time course for the induction and maintenance of tolerance to Delta(9)-tetrahydrocannabinol in mice","volume":"60","author":"Bass","year":"2000","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.bcp.2023.115665_b0080","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejphar.2004.06.009","article-title":"Reversal of delta 9-tetrahydrocannabinol-induced tolerance by specific kinase inhibitors","volume":"496","author":"Bass","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bcp.2023.115665_b0085","doi-asserted-by":"crossref","first-page":"214S","DOI":"10.1002\/j.1552-4604.1981.tb02598.x","article-title":"Cardiovascular and metabolic considerations in prolonged cannabinoid administration in man","volume":"21","author":"Benowitz","year":"1981","journal-title":"J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.bcp.2023.115665_b0090","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/0306-3623(94)00271-N","article-title":"Attenuation of tolerance to, and physical dependence on, morphine in the rat by inhibition of nitric oxide synthase","volume":"26","author":"Bhargava","year":"1995","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.bcp.2023.115665_b0095","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/ACO.0000000000000616","article-title":"An overview of the cannabinoid type 2 receptor system and its therapeutic potential","volume":"31","author":"Bie","year":"2018","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1016\/j.bcp.2023.115665_b0100","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1083\/jcb.200305129","article-title":"Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain","volume":"163","author":"Bisogno","year":"2003","journal-title":"J Cell Biol"},{"issue":"12","key":"10.1016\/j.bcp.2023.115665_b0105","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.chembiol.2007.11.006","article-title":"A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol","volume":"14","author":"Blankman","year":"2007","journal-title":"Chem Biol"},{"issue":"9","key":"10.1016\/j.bcp.2023.115665_b0110","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s40265-019-01132-x","article-title":"Cannabinoids: Current and Future Options to Treat Chronic and Chemotherapy-Induced Neuropathic Pain","volume":"79","author":"Blanton","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.bcp.2023.115665_b0115","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.brainresbull.2021.09.004","article-title":"Sex and dose-dependent antinociceptive effects of the JNK (c-Jun N-terminal kinase) inhibitor SU 3327 are mediated by CB2 receptors in female, and CB1\/CB2 receptors in male mice in an inflammatory pain model","volume":"177","author":"Blanton","year":"2021","journal-title":"Brain Res Bull"},{"issue":"1","key":"10.1016\/j.bcp.2023.115665_b0120","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1073\/pnas.012682399","article-title":"A pervasive mechanism for analgesia: activation of GIRK2 channels","volume":"100","author":"Blednov","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.bcp.2023.115665_b0125","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/jnc.13767","article-title":"Cannabinoid receptor interacting protein suppresses agonist-driven CB1 receptor internalization and regulates receptor replenishment in an agonist-biased manner","volume":"139","author":"Blume","year":"2016","journal-title":"J Neurochem"},{"key":"10.1016\/j.bcp.2023.115665_b0130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1124\/mol.116.104638","article-title":"Cannabinoid Receptor Interacting Protein 1a Competition with beta-Arrestin for CB1 Receptor Binding Sites","volume":"91","author":"Blume","year":"2017","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2023.115665_b0135","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/35047086","article-title":"Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence","volume":"408","author":"Bohn","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2023.115665_b0140","doi-asserted-by":"crossref","first-page":"10494","DOI":"10.1523\/JNEUROSCI.22-23-10494.2002","article-title":"Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knock-out mice","volume":"22","author":"Bohn","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2023.115665_b0145","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1126\/science.286.5449.2495","article-title":"Enhanced morphine analgesia in mice lacking beta-arrestin 2","volume":"286","author":"Bohn","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bcp.2023.115665_b0150","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1016\/j.febslet.2008.10.022","article-title":"Reciprocal influences of CB1 cannabinoid receptor agonists on ERK and JNK signalling in N1E\u2013115 cells","volume":"582","author":"Bosier","year":"2008","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bcp.2023.115665_b0155","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/npp.2008.138","article-title":"Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum","volume":"34","author":"Bossong","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"Pt 2","key":"10.1016\/j.bcp.2023.115665_b0160","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1042\/bj3120637","article-title":"Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1","volume":"312","author":"Bouaboula","year":"1995","journal-title":"Biochem J"},{"issue":"3","key":"10.1016\/j.bcp.2023.115665_b0165","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1432-1033.1996.0704p.x","article-title":"Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression","volume":"237","author":"Bouaboula","year":"1996","journal-title":"Eur J Biochem"},{"issue":"2","key":"10.1016\/j.bcp.2023.115665_b0170","doi-asserted-by":"crossref","first-page":"R349","DOI":"10.1152\/ajpregu.00933.2005","article-title":"Sex and hormonal cycle differences in rat brain levels of pain-related cannabimimetic lipid mediators","volume":"291","author":"Bradshaw","year":"2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.bcp.2023.115665_b0175","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1046\/j.1471-4159.1999.0732447.x","article-title":"Chronic delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain","volume":"73","author":"Breivogel","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.bcp.2023.115665_b0180","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/FBP.0b013e328308f1e6","article-title":"Sensitivity to delta9-tetrahydrocannabinol is selectively enhanced in beta-arrestin2 -\/- mice","volume":"19","author":"Breivogel","year":"2008","journal-title":"Behav Pharmacol"},{"issue":"1","key":"10.1016\/j.bcp.2023.115665_b0185","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3109\/10799893.2014.1003659","article-title":"The effects of beta-arrestin1 deletion on acute cannabinoid activity, brain cannabinoid receptors and tolerance to cannabinoids in mice","volume":"35","author":"Breivogel","year":"2015","journal-title":"J Recept Signal Transduct Res"},{"key":"10.1016\/j.bcp.2023.115665_b0190","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1176\/appi.ajp.161.11.1967","article-title":"Review of the validity and significance of cannabis withdrawal syndrome","volume":"161","author":"Budney","year":"2004","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.bcp.2023.115665_b0195","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.drugalcdep.2006.04.014","article-title":"Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms","volume":"86","author":"Budney","year":"2007","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.bcp.2023.115665_b0200","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jsat.2008.01.002","article-title":"Comparison of cannabis and tobacco withdrawal: severity and contribution to relapse","volume":"35","author":"Budney","year":"2008","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.bcp.2023.115665_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106560","article-title":"Peripheral sensory neuron CB2 cannabinoid receptors are necessary for both CB2-mediated antinociceptive efficacy and sparing of morphine tolerance in a mouse model of anti-retroviral toxic neuropathy","volume":"187","author":"Carey","year":"2023","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.bcp.2023.115665_b0210","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.drugalcdep.2014.08.005","article-title":"Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications","volume":"144","author":"Castaneto","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.bcp.2023.115665_b0215","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.2174\/13816128113199990430","article-title":"Male and female rats differ in brain cannabinoid CB1 receptor density and function and in behavioural traits predisposing to drug addiction: effect of ovarian hormones","volume":"20","author":"Castelli","year":"2014","journal-title":"Curr Pharm Des"},{"issue":"2","key":"10.1016\/j.bcp.2023.115665_b0220","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/adb.12116","article-title":"[18F]MK-9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users","volume":"20","author":"Ceccarini","year":"2015","journal-title":"Addict Biol"},{"key":"10.1016\/j.bcp.2023.115665_b0225","doi-asserted-by":"crossref","unstructured":"Chang L, Cash BD, Lembo A, Kunkel DC, English BA, Lindstrom B, Gu G, Skare S, Gilder K, Turner S, Cataldi F, Lipkis D and Jan T (2023) Efficacy and safety of olorinab, a full agonist of the cannabinoid receptor 2, for the treatment of abdominal pain in patients with irritable bowel syndrome: Results from a phase 2b randomized placebo-controlled trial (CAPTIVATE). Neurogastroenterol Motil:e14539.","DOI":"10.1111\/nmo.14539"},{"key":"10.1016\/j.bcp.2023.115665_b0230","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jcf.2020.09.008","article-title":"Safety and efficacy of lenabasum in a phase 2 randomized, placebo-controlled trial in adults with cystic fibrosis","volume":"20","author":"Chmiel","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.bcp.2023.115665_b0235","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1124\/jpet.116.232132","article-title":"Tolerance to the Diuretic Effects of Cannabinoids and Cross-Tolerance to a kappa-Opioid Agonist in THC-Treated Mice","volume":"358","author":"Chopda","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2023.115665_b0240","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0022-3565(24)38212-6","article-title":"Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification","volume":"289","author":"Cichewicz","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2023.115665_b0245","doi-asserted-by":"crossref","unstructured":"R. Cinar B.R. Gochuico M.R. Iyer T. Jourdan T. Yokoyama J.K. Park N.J. Coffey H. Pri-Chen G. Szanda Z. Liu K. Mackie W.A. Gahl G. Kunos Cannabinoid CB1 receptor overactivity contributes to the pathogenesis of idiopathic pulmonary fibrosis. JCI Insight 2 8 2017 2017 2017 2017.","DOI":"10.1172\/jci.insight.92281"},{"key":"10.1016\/j.bcp.2023.115665_b0250","first-page":"867","article-title":"A critical review of the safety and antiemetic efficacy of delta-9-tetrahydrocannabinol","volume":"15","author":"Cocchetto","year":"1981","journal-title":"Drug Intell Clin Pharm"},{"key":"10.1016\/j.bcp.2023.115665_b0255","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S0022-3565(24)37499-3","article-title":"CB1 receptor antagonist precipitates withdrawal in mice exposed to Delta9-tetrahydrocannabinol","volume":"285","author":"Cook","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2023.115665_b0260","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11920-016-0694-1","article-title":"Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal","volume":"18","author":"Cooper","year":"2016","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.bcp.2023.115665_b0265","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.drugalcdep.2013.12.013","article-title":"Investigation of sex-dependent effects of cannabis in daily cannabis smokers","volume":"136","author":"Cooper","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.bcp.2023.115665_b0270","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2016.08.001","article-title":"Sex-dependent effects of cannabis-induced analgesia","volume":"167","author":"Cooper","year":"2016","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.bcp.2023.115665_b0275","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/10550490500418997","article-title":"Cannabis withdrawal among non-treatment-seeking adult cannabis users","volume":"15","author":"Copersino","year":"2006","journal-title":"Am J Addict"},{"key":"10.1016\/j.bcp.2023.115665_b0280","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0169-328X(99)00053-4","article-title":"Time-dependent differences of repeated administration with Delta9-tetrahydrocannabinol in proenkephalin and cannabinoid receptor gene expression and G-protein activation by mu-opioid and CB1-cannabinoid receptors in the caudate-putamen","volume":"67","author":"Corchero","year":"1999","journal-title":"Brain Res Mol Brain Res"},{"issue":"1-2","key":"10.1016\/j.bcp.2023.115665_b0285","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.drugalcdep.2010.05.010","article-title":"Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults","volume":"112","author":"Cornelius","year":"2010","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.bcp.2023.115665_b0290","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1172\/JCI17725","article-title":"The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis","volume":"112","author":"Cota","year":"2003","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.bcp.2023.115665_b0295","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1523\/JNEUROSCI.21-07-02425.2001","article-title":"Agonist-induced internalization and trafficking of cannabinoid CB1 receptors in hippocampal neurons","volume":"21","author":"Coutts","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2023.115665_b0300","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.pain.2013.05.017","article-title":"Sex differences in anti-allodynic, anti-hyperalgesic and anti-edema effects of Delta(9)-tetrahydrocannabinol in the rat","volume":"154","author":"Craft","year":"2013","journal-title":"Pain"},{"issue":"8-9","key":"10.1016\/j.bcp.2023.115665_b0305","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.lfs.2012.06.009","article-title":"Sex differences in cannabinoid pharmacology: a reflection of differences in the endocannabinoid system?","volume":"92","author":"Craft","year":"2013","journal-title":"Life Sci"},{"key":"10.1016\/j.bcp.2023.115665_b0310","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1124\/jpet.111.188540","article-title":"Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat","volume":"340","author":"Craft","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"issue":"6604","key":"10.1016\/j.bcp.2023.115665_b0315","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/384083a0","article-title":"Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides","volume":"384","author":"Cravatt","year":"1996","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bcp.2023.115665_b0320","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrn.2016.28","article-title":"Keep off the grass? Cannabis, cognition and addiction","volume":"17","author":"Curran","year":"2016","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"10.1016\/j.bcp.2023.115665_b0325","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1089\/can.2016.0010","article-title":"Sex Differences in Cannabis Use and Effects: A Cross-Sectional Survey of Cannabis Users","volume":"1","author":"Cuttler","year":"2016","journal-title":"Cannabis Cannabinoid Res"},{"issue":"5-6","key":"10.1016\/j.bcp.2023.115665_b0330","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jpain.2019.11.001","article-title":"Short- and Long-Term Effects of Cannabis on Headache and Migraine","volume":"21","author":"Cuttler","year":"2020","journal-title":"J Pain"},{"key":"10.1016\/j.bcp.2023.115665_b0335","first-page":"60","article-title":"Rapid Changes in CB1 Receptor Availability in Cannabis Dependent Males after Abstinence from Cannabis","volume":"1","author":"D'Souza","year":"2016","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"10.1016\/j.bcp.2023.115665_b0340","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1038\/sj.npp.1301643","article-title":"Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis","volume":"33","author":"D'Souza","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"36","key":"10.1016\/j.bcp.2023.115665_b0345","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.15585\/mmwr.mm6736a2","article-title":"Prevalence of Chronic Pain and High-Impact Chronic Pain Among Adults - United States, 2016","volume":"67","author":"Dahlhamer","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.bcp.2023.115665_b0350","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neuropharm.2007.06.005","article-title":"Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1\/2 MAP kinase signaling","volume":"54","author":"Daigle","year":"2008","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.bcp.2023.115665_b0355","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1471-4159.2008.05336.x","article-title":"Regulation of CB1 cannabinoid receptor internalization by a promiscuous phosphorylation-dependent mechanism","volume":"106","author":"Daigle","year":"2008","journal-title":"J Neurochem"},{"issue":"3","key":"10.1016\/j.bcp.2023.115665_b0360","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.phrs.2005.03.004","article-title":"Protein Kinase A activity is increased in mouse lumbar spinal cord but not brain following morphine antinociceptive tolerance for 15 days","volume":"52","author":"Dalton","year":"2005","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.bcp.2023.115665_b0365","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0006-2952(98)00185-3","article-title":"Effects of cannabinoids on prolactin and gonadotrophin secretion: involvement of changes in hypothalamic gamma-aminobutyric acid (GABA) inputs","volume":"56","author":"de Miguel","year":"1998","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"10.1016\/j.bcp.2023.115665_b0370","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.biopsych.2014.04.009","article-title":"Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal","volume":"77","author":"Deng","year":"2015","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bcp.2023.115665_b0375","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/jnc.14628","article-title":"Mitogen-activated protein kinase signaling mediates opioid-induced presynaptic NMDA receptor activation and analgesic tolerance","volume":"148","author":"Deng","year":"2019","journal-title":"J Neurochem"},{"key":"10.1016\/j.bcp.2023.115665_b0380","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0026-895X(25)09876-1","article-title":"Determination and characterization of a cannabinoid receptor in rat brain","volume":"34","author":"Devane","year":"1988","journal-title":"Mol Pharmacol"},{"issue":"5090","key":"10.1016\/j.bcp.2023.115665_b0385","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.bcp.2023.115665_b0390","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev.physiol.69.022405.154749","article-title":"Beta-arrestins and cell signaling","volume":"69","author":"DeWire","year":"2007","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.bcp.2023.115665_b0395","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1046\/j.1471-4159.2000.0741627.x","article-title":"Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats","volume":"74","author":"Di Marzo","year":"2000","journal-title":"J Neurochem"},{"issue":"6507","key":"10.1016\/j.bcp.2023.115665_b0400","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/372686a0","article-title":"Formation and inactivation of endogenous cannabinoid anandamide in central neurons","volume":"372","author":"Di Marzo","year":"1994","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.bcp.2023.115665_b0405","doi-asserted-by":"crossref","first-page":"10819","DOI":"10.1073\/pnas.152334899","article-title":"Brain monoglyceride lipase participating in endocannabinoid inactivation","volume":"99","author":"Dinh","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.bcp.2023.115665_b0410","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nn.3892","article-title":"Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling","volume":"18","author":"Dudok","year":"2015","journal-title":"Nat Neurosci"},{"issue":"2","key":"10.1016\/j.bcp.2023.115665_b0415","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.addbeh.2009.09.009","article-title":"Cannabis dependence in the San Francisco Family Study: age of onset of use, DSM-IV symptoms, withdrawal, and heritability","volume":"35","author":"Ehlers","year":"2010","journal-title":"Addict Behav"},{"key":"10.1016\/j.bcp.2023.115665_b0420","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/08897070802218166","article-title":"Marijuana neurobiology and treatment","volume":"29","author":"Elkashef","year":"2008","journal-title":"Subst Abus"},{"issue":"7","key":"10.1016\/j.bcp.2023.115665_b0425","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.biopsych.2016.01.004","article-title":"Changes in Cannabis Potency Over the Last 2 Decades (1995\u20132014): Analysis of Current Data in the United States","volume":"79","author":"ElSohly","year":"2016","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bcp.2023.115665_b0430","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1038\/npp.2010.44","article-title":"FAAH-\/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration","volume":"35","author":"Falenski","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.bcp.2023.115665_b0435","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0006-8993(95)01113-7","article-title":"Cannabinoid receptor down-regulation without alteration of the inhibitory effect of CP 55,940 on adenylyl cyclase in the cerebellum of CP 55,940-tolerant mice","volume":"706","author":"Fan","year":"1996","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.bcp.2023.115665_b0440","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1017\/S003329171400107X","article-title":"Natural course of cannabis use disorders","volume":"45","author":"Farmer","year":"2015","journal-title":"Psychol Med"},{"key":"10.1016\/j.bcp.2023.115665_b0445","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.drugalcdep.2018.09.018","article-title":"Sex, THC, and hormones: Effects on density and sensitivity of CB(1) cannabinoid receptors in rats","volume":"194","author":"Farquhar","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"4245","key":"10.1016\/j.bcp.2023.115665_b0450","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1126\/science.1273591","article-title":"Residual learning deficit after heavy exposure to cannabis or alcohol in rats","volume":"192","author":"Fehr","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.bcp.2023.115665_b0455","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0026-895X(25)10492-6","article-title":"Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors","volume":"48","author":"Felder","year":"1995","journal-title":"Mol Pharmacol"},{"issue":"5","key":"10.1016\/j.bcp.2023.115665_b0460","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0896-6273(01)00517-7","article-title":"Endocytosis of the mu opioid receptor reduces tolerance and a cellular hallmark of opiate withdrawal","volume":"32","author":"Finn","year":"2001","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.bcp.2023.115665_b0465","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1152\/jn.01096.2006","article-title":"Effects of anandamide and noxious heat on intracellular calcium concentration in nociceptive drg neurons of rats","volume":"98","author":"Fischbach","year":"2007","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.bcp.2023.115665_b0470","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1038\/ncomms5589","article-title":"Ligand-specific endocytic dwell times control functional selectivity of the cannabinoid receptor 1","volume":"5","author":"Flores-Otero","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.bcp.2023.115665_b0475","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1124\/jpet.118.252965","article-title":"Reduced Tolerance and Asymmetrical Crosstolerance to Effects of the Indole Quinuclidinone Analog PNR-4-20, a G Protein-Biased Cannabinoid 1 Receptor Agonist in Mice: Comparisons with Delta(9)-Tetrahydrocannabinol and JWH-018","volume":"369","author":"Ford","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.bcp.2023.115665_b0480","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.tips.2016.12.003","article-title":"Synthetic Pot: Not Your Grandfather's Marijuana","volume":"38","author":"Ford","year":"2017","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bcp.2023.115665_b0485","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1046\/j.1471-4159.1996.67031309.x","article-title":"Functional coupling of the delta-, mu-, and kappa-opioid receptors to mitogen-activated protein kinase and arachidonate release in Chinese hamster ovary cells","volume":"67","author":"Fukuda","year":"1996","journal-title":"J Neurochem"},{"issue":"8","key":"10.1016\/j.bcp.2023.115665_b0490","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1523\/JNEUROSCI.18-08-02834.1998","article-title":"Protein kinase C disrupts cannabinoid actions by phosphorylation of the CB1 cannabinoid receptor","volume":"18","author":"Garcia","year":"1998","journal-title":"J Neurosci"},{"issue":"6197","key":"10.1016\/j.bcp.2023.115665_b0495","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/336385a0","article-title":"Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain","volume":"336","author":"Garthwaite","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2023.115665_b0500","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1744-8069-5-11","article-title":"Gz mediates the long-lasting desensitization of brain CB1 receptors and is essential for cross-tolerance with morphine","volume":"5","author":"Garzon","year":"2009","journal-title":"Mol Pain"},{"key":"10.1016\/j.bcp.2023.115665_b0505","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1007\/s00213-016-4237-6","article-title":"Delta(9)-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids in mice and rats","volume":"233","author":"Gatch","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"issue":"19","key":"10.1016\/j.bcp.2023.115665_b0510","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1007\/s00213-015-4023-x","article-title":"Cross-tolerance to cannabinoids in morphine-tolerant rhesus monkeys","volume":"232","author":"Gerak","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bcp.2023.115665_b0515","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neuropharm.2016.12.018","article-title":"The CB1 receptor is required for the establishment of the hyperlocomotor phenotype in developmentally-induced hypothyroidism in mice","volume":"116","author":"Gine","year":"2017","journal-title":"Neuropharmacology"},{"issue":"14","key":"10.1016\/j.bcp.2023.115665_b0520","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1523\/JNEUROSCI.17-14-05327.1997","article-title":"Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor","volume":"17","author":"Glass","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2023.115665_b0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108374","article-title":"Chronic cannabinoid exposure produces tolerance to the dopamine releasing effects of WIN 55,212\u20132 and heroin in adult male rats","volume":"182","author":"Gomez","year":"2021","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.bcp.2023.115665_b0530","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1006\/bbrc.2000.2406","article-title":"Sex steroid influence on cannabinoid CB(1) receptor mRNA and endocannabinoid levels in the anterior pituitary gland","volume":"270","author":"Gonz\u00e1lez","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.bcp.2023.115665_b0535","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.pbb.2005.01.028","article-title":"Cannabinoid tolerance and dependence: a review of studies in laboratory animals","volume":"81","author":"Gonzalez","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bcp.2023.115665_b0540","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000054468","article-title":"Identification of endocannabinoids and cannabinoid CB(1) receptor mRNA in the pituitary gland","volume":"70","author":"Gonzalez","year":"1999","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.bcp.2023.115665_b0545","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/jat\/bks081","article-title":"Tolerance to effects of high-dose oral delta9-tetrahydrocannabinol and plasma cannabinoid concentrations in male daily cannabis smokers","volume":"37","author":"Gorelick","year":"2013","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.bcp.2023.115665_b0550","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pain.2005.12.007","article-title":"Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti-inflammatory drug, in acute and inflammatory pain","volume":"121","author":"Guindon","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.bcp.2023.115665_b0555","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/sj.bjp.0706990","article-title":"The antinociceptive effects of intraplantar injections of 2-arachidonoyl glycerol are mediated by cannabinoid CB2 receptors","volume":"150","author":"Guindon","year":"2007","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.bcp.2023.115665_b0560","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.pbb.2011.04.012","article-title":"Role of GLT-1 transporter activation in prevention of cannabinoid tolerance by the beta-lactam antibiotic, ceftriaxone, in mice","volume":"99","author":"Gunduz","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"issue":"5","key":"10.1016\/j.bcp.2023.115665_b0565","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1152\/jn.2000.84.5.2356","article-title":"Cannabinoid and kappa opioid receptors reduce potassium K current via activation of G(s) proteins in cultured hippocampal neurons","volume":"84","author":"Hampson","year":"2000","journal-title":"J Neurophysiol"},{"issue":"5","key":"10.1016\/j.bcp.2023.115665_b0570","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/hipo.10081","article-title":"Tolerance to the memory disruptive effects of cannabinoids involves adaptation by hippocampal neurons","volume":"13","author":"Hampson","year":"2003","journal-title":"Hippocampus"},{"issue":"6","key":"10.1016\/j.bcp.2023.115665_b0575","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/sj.npp.1301243","article-title":"Opioid antagonism of cannabinoid effects: differences between marijuana smokers and nonmarijuana smokers","volume":"32","author":"Haney","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.bcp.2023.115665_b0580","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s002130050849","article-title":"Abstinence symptoms following smoked marijuana in humans","volume":"141","author":"Haney","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.bcp.2023.115665_b0585","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s002130000657","article-title":"Bupropion SR worsens mood during marijuana withdrawal in humans","volume":"155","author":"Haney","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"issue":"12","key":"10.1016\/j.bcp.2023.115665_b0590","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1039\/C6NP00074F","article-title":"Phytocannabinoids: a unified critical inventory","volume":"33","author":"Hanu\u0161","year":"2016","journal-title":"Nat Prod Rep"},{"issue":"3","key":"10.1016\/j.bcp.2023.115665_b0595","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/02791072.2013.805976","article-title":"The medicinal use of cannabis and cannabinoids\u2013an international cross-sectional survey on administration forms","volume":"45","author":"Hazekamp","year":"2013","journal-title":"J Psychoactive Drugs"},{"key":"10.1016\/j.bcp.2023.115665_b0600","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.684115","article-title":"Sex Differences in Tolerance to Delta-9-Tetrahydrocannabinol in Mice With Cisplatin-Evoked Chronic Neuropathic Pain","volume":"8","author":"Henderson-Redmond","year":"2021","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.bcp.2023.115665_b0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107847","article-title":"c-Jun N terminal kinase signaling pathways mediate cannabinoid tolerance in an agonist-specific manner","volume":"164","author":"Henderson-Redmond","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2023.115665_b0610","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s00213-021-05886-9","article-title":"Sex-specific mechanisms of tolerance for the cannabinoid agonists CP55,940 and delta-9-tetrahydrocannabinol (Delta(9)-THC)","volume":"239","author":"Henderson-Redmond","year":"2022","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.bcp.2023.115665_b0615","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","article-title":"Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study","volume":"11","author":"Herkenham","year":"1991","journal-title":"J Neurosci"},{"issue":"5","key":"10.1016\/j.bcp.2023.115665_b0620","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","article-title":"Cannabinoid receptor localization in brain","volume":"87","author":"Herkenham","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.bcp.2023.115665_b0625","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.drugalcdep.2004.02.001","article-title":"Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment","volume":"74","author":"Hernandez-Avila","year":"2004","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.bcp.2023.115665_b0630","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1037\/pha0000053","article-title":"Sex differences in cannabis withdrawal symptoms among treatment-seeking cannabis users","volume":"23","author":"Herrmann","year":"2015","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/j.bcp.2023.115665_b0635","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/BF00431774","article-title":"Morphine and delta 9-tetrahydrocannabinol: two-way cross tolerance for antinociceptive and heart-rate responses in the rat","volume":"87","author":"Hine","year":"1985","journal-title":"Psychopharmacology (Berl)"},{"issue":"6","key":"10.1016\/j.bcp.2023.115665_b0640","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/mp.2011.82","article-title":"Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers","volume":"17","author":"Hirvonen","year":"2012","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bcp.2023.115665_b0645","first-page":"363","article-title":"Coupling of the expressed cannabinoid CB1 and CB2 receptors to phospholipase C and G protein-coupled inwardly rectifying K+ channels","volume":"6","author":"Ho","year":"1999","journal-title":"Recept Channels"},{"key":"10.1016\/j.bcp.2023.115665_b0650","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0026-895X(25)12377-8","article-title":"Cannabinoid inhibition of adenylate cyclase. Biochemistry of the response in neuroblastoma cell membranes","volume":"27","author":"Howlett","year":"1985","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2023.115665_b0655","series-title":"Cannabinoid receptor signaling","author":"Howlett","year":"2005"},{"key":"10.1016\/j.bcp.2023.115665_b0660","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0026-895X(25)15066-9","article-title":"Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes","volume":"26","author":"Howlett","year":"1984","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2023.115665_b0665","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0026-895X(25)10219-8","article-title":"Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs","volume":"29","author":"Howlett","year":"1986","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2023.115665_b0670","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1124\/jpet.112.196444","article-title":"Apparent inverse relationship between cannabinoid agonist efficacy and tolerance\/cross-tolerance produced by Delta(9)-tetrahydrocannabinol treatment in rhesus monkeys","volume":"342","author":"Hruba","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2023.115665_b0675","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1471-4159.1999.0730493.x","article-title":"Internalization and recycling of the CB1 cannabinoid receptor","volume":"73","author":"Hsieh","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.bcp.2023.115665_b0680","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-3565(25)32251-2","article-title":"Tolerance and disposition of tetrahydrocannabinol in man","volume":"215","author":"Hunt","year":"1980","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2023.115665_b0685","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/sj.bjp.0702228","article-title":"Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinol","volume":"125","author":"Hutcheson","year":"1998","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.bcp.2023.115665_b0690","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1089\/can.2016.0037","article-title":"Cannabinoid CB(1) and CB(2) Receptor Signaling and Bias","volume":"2","author":"Ibsen","year":"2017","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.bcp.2023.115665_b0695","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3389\/fphar.2019.00350","article-title":"Cannabinoid CB1 and CB2 Receptor-Mediated Arrestin Translocation: Species, Subtype, and Agonist-Dependence","volume":"10","author":"Ibsen","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bcp.2023.115665_b0700","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0091-3057(01)00647-5","article-title":"Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids","volume":"71","author":"Janoyan","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"issue":"13","key":"10.1016\/j.bcp.2023.115665_b0705","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1002\/cne.25334","article-title":"Sex-specific cannabinoid 1 receptors on GABAergic neurons in the ventrolateral periaqueductal gray mediate analgesia in mice","volume":"530","author":"Jiang","year":"2022","journal-title":"J Comp Neurol"},{"issue":"10","key":"10.1016\/j.bcp.2023.115665_b0710","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1523\/JNEUROSCI.19-10-03773.1999","article-title":"Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization","volume":"19","author":"Jin","year":"1999","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.bcp.2023.115665_b0715","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/jat\/bkv133","article-title":"A Retrospective Analysis of Urine Drugs of Abuse Immunoassay True Positive Rates at a National Reference Laboratory","volume":"40","author":"Johnson-Davis","year":"2016","journal-title":"J Anal Toxicol"},{"issue":"24","key":"10.1016\/j.bcp.2023.115665_b0720","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1007\/s00213-014-3611-5","article-title":"Lithium carbonate in the management of cannabis withdrawal: a randomized placebo-controlled trial in an inpatient setting","volume":"231","author":"Johnston","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"issue":"1 Chronic Canna","key":"10.1016\/j.bcp.2023.115665_b0725","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1749-6632.1976.tb49901.x","article-title":"Clinical studies of cannabis tolerance and dependence","volume":"282","author":"Jones","year":"1976","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.bcp.2023.115665_b0730","doi-asserted-by":"crossref","first-page":"143S","DOI":"10.1002\/j.1552-4604.1981.tb02589.x","article-title":"Clinical relevance of cannabis tolerance and dependence","volume":"21","author":"Jones","year":"1981","journal-title":"J Clin Pharmacol"},{"issue":"1-3","key":"10.1016\/j.bcp.2023.115665_b0735","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejphar.2008.02.055","article-title":"Modulation by female sex hormones of the cannabinoid-induced catalepsy and analgesia in ovariectomized mice","volume":"586","author":"Kalbasi Anaraki","year":"2008","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.bcp.2023.115665_b0740","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1152\/physrev.00019.2008","article-title":"Endocannabinoid-mediated control of synaptic transmission","volume":"89","author":"Kano","year":"2009","journal-title":"Physiol Rev"},{"key":"10.1016\/j.bcp.2023.115665_b0745","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.addbeh.2017.07.012","article-title":"DSM-5 cannabis use disorder in the National Epidemiologic Survey on Alcohol and Related Conditions-III: Gender-specific profiles","volume":"76","author":"Kerridge","year":"2018","journal-title":"Addict Behav"},{"key":"10.1016\/j.bcp.2023.115665_b0750","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fnmol.2020.00125","article-title":"Cannabinoids","volume":"13","author":"Kesner","year":"2020","journal-title":"Endocannabinoids and Sleep. Front Mol Neurosci"},{"key":"10.1016\/j.bcp.2023.115665_b0755","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/s41386-022-01326-0","article-title":"Changes in striatal dopamine release, sleep, and behavior during spontaneous Delta-9-tetrahydrocannabinol abstinence in male and female mice","volume":"47","author":"Kesner","year":"2022","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.bcp.2023.115665_b0760","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1124\/mol.115.099192","article-title":"Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor","volume":"88","author":"Khajehali","year":"2015","journal-title":"Mol Pharmacol"},{"issue":"1-3","key":"10.1016\/j.bcp.2023.115665_b0765","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.drugalcdep.2012.10.015","article-title":"Gender differences in cannabis use disorders: results from the National Epidemiologic Survey of Alcohol and Related Conditions","volume":"130","author":"Khan","year":"2013","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.bcp.2023.115665_b0770","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cub.2007.12.057","article-title":"Morphine-induced receptor endocytosis in a novel knockin mouse reduces tolerance and dependence","volume":"18","author":"Kim","year":"2008","journal-title":"Curr Biol"},{"issue":"3","key":"10.1016\/j.bcp.2023.115665_b0775","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1124\/jpet.112.201426","article-title":"Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1-mediated antinociceptive and gastroprotective effects","volume":"345","author":"Kinsey","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2023.115665_b0780","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuroscience.2021.11.007","article-title":"Cannabinoid Receptor Type 2 Agonist Reduces Morphine Tolerance via Mitogen Activated Protein Kinase Phosphatase Induction and Mitogen Activated Protein Kinase Dephosphorylation","volume":"480","author":"Kong","year":"2022","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.bcp.2023.115665_b0785","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0026-895X(24)12110-4","article-title":"Desensitization of cannabinoid-mediated presynaptic inhibition of neurotransmission between rat hippocampal neurons in culture","volume":"61","author":"Kouznetsova","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2023.115665_b0790","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0026-895X(24)13072-6","article-title":"Agonist induced homologous desensitization of mu-opioid receptors mediated by G protein-coupled receptor kinases is dependent on agonist efficacy","volume":"54","author":"Kovoor","year":"1998","journal-title":"Mol Pharmacol"},{"issue":"3","key":"10.1016\/j.bcp.2023.115665_b0795","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0896-6273(01)00246-X","article-title":"Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells","volume":"29","author":"Kreitzer","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.bcp.2023.115665_b0800","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/WNR.0000000000000993","article-title":"Sex differences in antinociceptive response to Delta-9-tetrahydrocannabinol and CP 55,940 in the mouse formalin test","volume":"29","author":"LaFleur","year":"2018","journal-title":"Neuroreport"},{"issue":"3","key":"10.1016\/j.bcp.2023.115665_b0805","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1124\/mol.115.101980","article-title":"Biased Type 1 Cannabinoid Receptor Signaling Influences Neuronal Viability in a Cell Culture Model of Huntington Disease","volume":"89","author":"Laprairie","year":"2016","journal-title":"Mol Pharmacol"},{"issue":"52","key":"10.1016\/j.bcp.2023.115665_b0810","doi-asserted-by":"crossref","first-page":"19144","DOI":"10.1073\/pnas.0509588102","article-title":"The cannabinoid agonist WIN55,212\u20132 increases intracellular calcium via CB1 receptor coupling to Gq\/11 G proteins","volume":"102","author":"Lauckner","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5400","key":"10.1016\/j.bcp.2023.115665_b0815","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1126\/science.283.5400.401","article-title":"Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice","volume":"283","author":"Ledent","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bcp.2023.115665_b0820","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1124\/jpet.102.044446","article-title":"The role of several kinases in mice tolerant to delta 9-tetrahydrocannabinol","volume":"305","author":"Lee","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2023.115665_b0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2020.106479","article-title":"What is the prevalence and risk of cannabis use disorders among people who use cannabis? a systematic review and meta-analysis","volume":"109","author":"Leung","year":"2020","journal-title":"Addict Behav"},{"issue":"1","key":"10.1016\/j.bcp.2023.115665_b0830","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/10550490490265280","article-title":"Pharmacotherapy for marijuana dependence: a double-blind, placebo-controlled pilot study of divalproex sodium","volume":"13","author":"Levin","year":"2004","journal-title":"Am J Addict"},{"issue":"1-2","key":"10.1016\/j.bcp.2023.115665_b0835","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.drugalcdep.2010.04.010","article-title":"Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers","volume":"111","author":"Levin","year":"2010","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"10.1016\/j.bcp.2023.115665_b0840","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.1021\/acsomega.7b00996","article-title":"Chemical Profiling of Medical Cannabis Extracts","volume":"2","author":"Lewis","year":"2017","journal-title":"ACS Omega"},{"issue":"2","key":"10.1016\/j.bcp.2023.115665_b0845","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1124\/mol.118.113233","article-title":"Cannabinoid CB2 Agonist AM1710 Differentially Suppresses Distinct Pathological Pain States and Attenuates Morphine Tolerance and Withdrawal","volume":"95","author":"Li","year":"2019","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2023.115665_b0850","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0091-3057(01)00514-7","article-title":"Precipitated cannabinoid withdrawal is reversed by Delta(9)-tetrahydrocannabinol or clonidine","volume":"69","author":"Lichtman","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bcp.2023.115665_b0855","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0022-3565(24)29469-6","article-title":"Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice","volume":"298","author":"Lichtman","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"issue":"2-3","key":"10.1016\/j.bcp.2023.115665_b0860","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0014-2999(98)00558-5","article-title":"Effects of SR 141716A after acute or chronic cannabinoid administration in dogs","volume":"357","author":"Lichtman","year":"1998","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.bcp.2023.115665_b0865","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1124\/mol.117.109355","article-title":"Slowly Signaling G Protein-Biased CB(2) Cannabinoid Receptor Agonist LY2828360 Suppresses Neuropathic Pain with Sustained Efficacy and Attenuates Morphine Tolerance and Dependence","volume":"93","author":"Lin","year":"2018","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2023.115665_b0870","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0173(01)00057-1","article-title":"Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence","volume":"38","author":"Liu","year":"2001","journal-title":"Brain Res Brain Res Rev"},{"issue":"1","key":"10.1016\/j.bcp.2023.115665_b0875","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nchembio.129","article-title":"Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects","volume":"5","author":"Long","year":"2009","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.bcp.2023.115665_b0880","doi-asserted-by":"crossref","DOI":"10.1007\/3-540-26573-2_10","article-title":"Distribution of cannabinoid receptors in the central and peripheral nervous system","author":"Mackie","year":"2005","journal-title":"Handb Exp Pharmacol:299\u2013325."},{"key":"10.1016\/j.bcp.2023.115665_b0885","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0026-895X(25)13215-X","article-title":"Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells","volume":"44","author":"Mackie","year":"1993","journal-title":"Mol Pharmacol"},{"issue":"9","key":"10.1016\/j.bcp.2023.115665_b0890","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1073\/pnas.89.9.3825","article-title":"Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells","volume":"89","author":"Mackie","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.bcp.2023.115665_b0895","doi-asserted-by":"crossref","first-page":"6552","DOI":"10.1523\/JNEUROSCI.15-10-06552.1995","article-title":"Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor","volume":"15","author":"Mackie","year":"1995","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.bcp.2023.115665_b0900","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0896-6273(01)00375-0","article-title":"Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors","volume":"31","author":"Maejima","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.bcp.2023.115665_b0905","doi-asserted-by":"crossref","first-page":"6826","DOI":"10.1523\/JNEUROSCI.0945-05.2005","article-title":"Synaptically driven endocannabinoid release requires Ca2+-assisted metabotropic glutamate receptor subtype 1 to phospholipase Cbeta4 signaling cascade in the cerebellum","volume":"25","author":"Maejima","year":"2005","journal-title":"J Neurosci"},{"issue":"2-3","key":"10.1016\/j.bcp.2023.115665_b0910","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejphar.2011.04.010","article-title":"The effect of chronic opioid vs. cannabinoid exposure on the expression of tolerance to morphine- or WIN-55,212-2-induced analgesia and hypothermia in the guinea pig","volume":"660","author":"Maguma","year":"2011","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.bcp.2023.115665_b0915","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/0306-4522(92)90409-U","article-title":"Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry","volume":"48","author":"Mailleux","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.bcp.2023.115665_b0920","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0304-3959(96)81972-5","article-title":"Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance","volume":"67","author":"Manning","year":"1996","journal-title":"Pain"},{"key":"10.1016\/j.bcp.2023.115665_b0925","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12990-015-0031-4","article-title":"Tolerance to the antinociceptive effects of chronic morphine requires c-Jun N-terminal kinase","volume":"11","author":"Marcus","year":"2015","journal-title":"Mol Pain"},{"issue":"8","key":"10.1016\/j.bcp.2023.115665_b0930","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/nn.2601","article-title":"The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors","volume":"13","author":"Marrs","year":"2010","journal-title":"Nat Neurosci"},{"issue":"6-7","key":"10.1016\/j.bcp.2023.115665_b0935","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0024-3205(99)00281-7","article-title":"Discovery and characterization of endogenous cannabinoids","volume":"65","author":"Martin","year":"1999","journal-title":"Life Sci"},{"issue":"6","key":"10.1016\/j.bcp.2023.115665_b0940","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.tips.2004.04.005","article-title":"Signaling pathways involved in the development of cannabinoid tolerance","volume":"25","author":"Martin","year":"2004","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.bcp.2023.115665_b0945","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1096\/fj.06-7132com","article-title":"Ligand-induced down-regulation of the cannabinoid 1 receptor is mediated by the G-protein-coupled receptor-associated sorting protein GASP1","volume":"21","author":"Martini","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.bcp.2023.115665_b0950","doi-asserted-by":"crossref","first-page":"e12870","DOI":"10.1111\/adb.12870","article-title":"Reduced responsiveness of the reward system is associated with tolerance to cannabis impairment in chronic users","volume":"26","author":"Mason","year":"2021","journal-title":"Addict Biol"},{"issue":"2","key":"10.1016\/j.bcp.2023.115665_b0955","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00213-019-05369-y","article-title":"Sex differences in the acute effects of smoked cannabis: evidence from a human laboratory study of young adults","volume":"237","author":"Matheson","year":"2020","journal-title":"Psychopharmacology (Berl)"},{"issue":"6284","key":"10.1016\/j.bcp.2023.115665_b0960","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2023.115665_b0965","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1124\/jpet.107.130328","article-title":"Dose-related differences in the regional pattern of cannabinoid receptor adaptation and in vivo tolerance development to delta9-tetrahydrocannabinol","volume":"324","author":"McKinney","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2023.115665_b0970","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.drugalcdep.2015.08.013","article-title":"Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial","volume":"156","author":"McRae-Clark","year":"2015","journal-title":"Drug Alcohol Depend"},{"issue":"25","key":"10.1016\/j.bcp.2023.115665_b0975","doi-asserted-by":"crossref","first-page":"11608","DOI":"10.1073\/pnas.1000751107","article-title":"Ligand-directed c-Jun N-terminal kinase activation disrupts opioid receptor signaling","volume":"107","author":"Melief","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bcp.2023.115665_b0980","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.pain.2006.06.016","article-title":"Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain","volume":"126","author":"Mitrirattanakul","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.bcp.2023.115665_b0985","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0006-8993(00)01998-3","article-title":"Acute and long-term effects of 17beta-estradiol on G(i\/o) coupled neurotransmitter receptor function in the female rat brain as assessed by agonist-stimulated [35S]GTPgammaS binding","volume":"859","author":"Mize","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.bcp.2023.115665_b0990","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111283","article-title":"CB2 agonism controls pain and subchondral bone degeneration induced by mono-iodoacetate: Implications GPCR functional bias and tolerance development","volume":"136","author":"Mlost","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bcp.2023.115665_b0995","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1460-9568.2007.05322.x","article-title":"CB2 cannabinoid receptors promote mouse neural stem cell proliferation","volume":"25","author":"Molina-Holgado","year":"2007","journal-title":"Eur J Neurosci"},{"issue":"1","key":"10.1016\/j.bcp.2023.115665_b1000","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev.physiol.69.022405.154712","article-title":"Regulation of receptor trafficking by GRKs and arrestins","volume":"69","author":"Moore","year":"2007","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.bcp.2023.115665_b1005","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00213-021-05995-5","article-title":"Cannabinoid tetrad effects of oral Delta9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations","volume":"239","author":"Moore","year":"2022","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bcp.2023.115665_b1010","first-page":"103","article-title":"Molecular Targets of the Phytocannabinoids: A Complex Picture","volume":"103","author":"Morales","year":"2017","journal-title":"Prog Chem Org Nat Prod"},{"issue":"15","key":"10.1016\/j.bcp.2023.115665_b1015","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.1523\/JNEUROSCI.3445-12.2014","article-title":"Mutation of putative GRK phosphorylation sites in the cannabinoid receptor 1 (CB1R) confers resistance to cannabinoid tolerance and hypersensitivity to cannabinoids in mice","volume":"34","author":"Morgan","year":"2014","journal-title":"J Neurosci"},{"issue":"6441","key":"10.1016\/j.bcp.2023.115665_b1020","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.bcp.2023.115665_b1025","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jpain.2015.05.002","article-title":"Estimates of pain prevalence and severity in adults: United States, 2012","volume":"16","author":"Nahin","year":"2015","journal-title":"J Pain"},{"key":"10.1016\/j.bcp.2023.115665_b1030","unstructured":"National Academies of Sciences E and Medicine (2017) The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research, The National Academies Press, Washington, DC."},{"key":"10.1016\/j.bcp.2023.115665_b1035","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neuropharm.2018.12.026","article-title":"Tolerance to WIN55,212\u20132 is delayed in desensitization-resistant S426A\/S430A mice","volume":"148","author":"Nealon","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2023.115665_b1040","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/bph.14856","article-title":"Lasting effects of repeated \u0394(9) -tetrahydrocannabinol vapour inhalation during adolescence in male and female rats","volume":"177","author":"Nguyen","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2023.115665_b1045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pbb.2018.07.007","article-title":"Tolerance to hypothermic and antinoceptive effects of \u03949-tetrahydrocannabinol (THC) vapor inhalation in rats","volume":"172","author":"Nguyen","year":"2018","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bcp.2023.115665_b1050","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.biopsych.2011.11.027","article-title":"beta-arrestin2 regulates cannabinoid CB1 receptor signaling and adaptation in a central nervous system region-dependent manner","volume":"71","author":"Nguyen","year":"2012","journal-title":"Biol Psychiatry"},{"issue":"6","key":"10.1016\/j.bcp.2023.115665_b1055","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1124\/mol.107.039263","article-title":"CB1 cannabinoid receptor activity is modulated by the cannabinoid receptor interacting protein CRIP 1a","volume":"72","author":"Niehaus","year":"2007","journal-title":"Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.bcp.2023.115665_b1060","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/1556-4029.13819","article-title":"Cannabinoid Hyperemesis Syndrome: Reports of Fatal Cases","volume":"64","author":"Nourbakhsh","year":"2019","journal-title":"J Forensic Sci"},{"issue":"5","key":"10.1016\/j.bcp.2023.115665_b1065","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1172\/JCI200523057","article-title":"Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity","volume":"115","author":"Osei-Hyiaman","year":"2005","journal-title":"J Clin Invest"},{"issue":"1-2","key":"10.1016\/j.bcp.2023.115665_b1070","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0006-8993(93)90220-H","article-title":"Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study","volume":"616","author":"Oviedo","year":"1993","journal-title":"Brain Res"},{"issue":"38","key":"10.1016\/j.bcp.2023.115665_b1075","doi-asserted-by":"crossref","first-page":"13420","DOI":"10.1523\/JNEUROSCI.2075-11.2011","article-title":"Alterations of endocannabinoid signaling, synaptic plasticity, learning, and memory in monoacylglycerol lipase knock-out mice","volume":"31","author":"Pan","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2023.115665_b1080","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1089\/can.2019.0047","article-title":"Sex and Strain Variation in Initial Sensitivity and Rapid Tolerance to Delta9-Tetrahydrocannabinol","volume":"5","author":"Parks","year":"2020","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.bcp.2023.115665_b1085","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1111\/bph.15748","article-title":"Delineating the interactions between the cannabinoid CB(2) receptor and its regulatory effectors; beta-arrestins and GPCR kinases","volume":"179","author":"Patel","year":"2022","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.bcp.2023.115665_b1090","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.drugalcdep.2005.01.008","article-title":"Transdermal nicotine alters some of marihuana's effects in male and female volunteers","volume":"79","author":"Penetar","year":"2005","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.bcp.2023.115665_b1095","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1017\/S0029665113003649","article-title":"Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications","volume":"73","author":"Pertwee","year":"2014","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.bcp.2023.115665_b1100","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1111\/j.1476-5381.1993.tb13989.x","article-title":"Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212\u20132 and anandamide","volume":"110","author":"Pertwee","year":"1993","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2023.115665_b1105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1124\/jpet.122.001367","article-title":"Cannabinoid Tolerance in S426A\/S430A x beta-Arrestin 2 Knockout Double-Mutant Mice","volume":"385","author":"Piscura","year":"2023","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2023.115665_b1110","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0304-3940(03)00159-9","article-title":"Mifepristone or inhibition of 11beta-hydroxylase activity potentiates the sedating effects of the cannabinoid receptor-1 agonist Delta(9)-tetrahydrocannabinol in mice","volume":"341","author":"Pryce","year":"2003","journal-title":"Neurosci Lett"},{"issue":"3","key":"10.1016\/j.bcp.2023.115665_b1115","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/ilar.52.3.295","article-title":"Marijuana dependence: not just smoke and mirrors","volume":"52","author":"Ramesh","year":"2011","journal-title":"ILAR J"},{"issue":"4","key":"10.1016\/j.bcp.2023.115665_b1120","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00213-008-1422-2","article-title":"The effects of cannabinoids on serum cortisol and prolactin in humans","volume":"203","author":"Ranganathan","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.bcp.2023.115665_b1125","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/sj.ijo.0802583","article-title":"CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity","volume":"28","author":"Ravinet Trillou","year":"2004","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"4","key":"10.1016\/j.bcp.2023.115665_b1130","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1185\/030079908X280635","article-title":"Analgesic and antihyperalgesic effects of nabilone on experimental heat pain","volume":"24","author":"John Redmond","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.bcp.2023.115665_b1135","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.803331","article-title":"Modulation of Morphine Analgesia, Antinociceptive Tolerance, and Mu-Opioid Receptor Binding by the Cannabinoid CB2 Receptor Agonist O-1966","volume":"13","author":"Reichenbach","year":"2022","journal-title":"Front Pharmacol"},{"issue":"8","key":"10.1016\/j.bcp.2023.115665_b1140","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.psyneuen.2010.02.008","article-title":"Estrogenic regulation of limbic cannabinoid receptor binding","volume":"35","author":"Riebe","year":"2010","journal-title":"Psychoneuroendocrinology"},{"issue":"2-3","key":"10.1016\/j.bcp.2023.115665_b1145","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0014-5793(94)00773-X","article-title":"SR141716A, a potent and selective antagonist of the brain cannabinoid receptor","volume":"350","author":"Rinaldi-Carmona","year":"1994","journal-title":"FEBS Lett"},{"issue":"2","key":"10.1016\/j.bcp.2023.115665_b1150","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0165-3806(02)00306-1","article-title":"Antinociceptive, behavioural and neuroendocrine effects of CP 55,940 in young rats","volume":"136","author":"Romero","year":"2002","journal-title":"Brain Res Dev Brain Res"},{"key":"10.1016\/j.bcp.2023.115665_b1155","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1385\/JMN:11:2:109","article-title":"Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTP gamma S binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to delta 9-tetrahydrocannabinol","volume":"11","author":"Romero","year":"1998","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.bcp.2023.115665_b1160","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0169-328X(96)00277-X","article-title":"Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions","volume":"46","author":"Romero","year":"1997","journal-title":"Brain Res Mol Brain Res"},{"issue":"2","key":"10.1016\/j.bcp.2023.115665_b1165","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.neulet.2009.09.027","article-title":"No association between chronic cannabis use and loudness dependence of auditory evoked potentials as indicator of central serotonergic neurotransmission","volume":"465","author":"Roser","year":"2009","journal-title":"Neurosci Lett"},{"issue":"11","key":"10.1016\/j.bcp.2023.115665_b1170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080022","article-title":"The cannabinoid receptor type 2 as mediator of mesenchymal stromal cell immunosuppressive properties","volume":"8","author":"Rossi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2023.115665_b1175","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/0024-3205(95)00183-7","article-title":"A novel class of potent tetrahydrocannabinols (THCS): 2'-yne-delta 8- and delta 9-THCS","volume":"56","author":"Ryan","year":"1995","journal-title":"Life Sci"},{"key":"10.1016\/j.bcp.2023.115665_b1180","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","article-title":"The orphan receptor GPR55 is a novel cannabinoid receptor","volume":"152","author":"Ryberg","year":"2007","journal-title":"Br J Pharmacol"},{"issue":"1712","key":"10.1016\/j.bcp.2023.115665_b1185","first-page":"e1713","article-title":"Withdrawal seizures seen in the setting of synthetic cannabinoid abuse","volume":"33","author":"Sampson","year":"2015","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.bcp.2023.115665_b1190","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41467-017-00791-2","article-title":"Peroxiredoxin 6 mediates Galphai protein-coupled receptor inactivation by cJun kinase","volume":"8","author":"Schattauer","year":"2017","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.bcp.2023.115665_b1195","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/nn.2616","article-title":"Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system","volume":"13","author":"Schlosburg","year":"2010","journal-title":"Nat Neurosci"},{"issue":"2","key":"10.1016\/j.bcp.2023.115665_b1200","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1208\/s12248-009-9110-7","article-title":"Inhibitors of endocannabinoid-metabolizing enzymes reduce precipitated withdrawal responses in THC-dependent mice","volume":"11","author":"Schlosburg","year":"2009","journal-title":"AAPS J"},{"issue":"2","key":"10.1016\/j.bcp.2023.115665_b1205","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1124\/jpet.114.212753","article-title":"Prolonged monoacylglycerol lipase blockade causes equivalent cannabinoid receptor type 1 receptor-mediated adaptations in fatty acid amide hydrolase wild-type and knockout mice","volume":"350","author":"Schlosburg","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.bcp.2023.115665_b1210","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00213-017-4749-8","article-title":"Adolescent cannabinoid exposure effects on natural reward seeking and learning in rats","volume":"235","author":"Schoch","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.bcp.2023.115665_b1215","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/ajad.12503","article-title":"Gender differences among treatment-seeking adults with cannabis use disorder: Clinical profiles of women and men enrolled in the achieving cannabis cessation-evaluating N-acetylcysteine treatment (ACCENT) study","volume":"26","author":"Sherman","year":"2017","journal-title":"Am J Addict"},{"issue":"2","key":"10.1016\/j.bcp.2023.115665_b1220","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1124\/jpet.105.085282","article-title":"The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors","volume":"314","author":"Shoemaker","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.bcp.2023.115665_b1225","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1124\/jpet.105.089474","article-title":"Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors","volume":"315","author":"Shoemaker","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.bcp.2023.115665_b1230","doi-asserted-by":"crossref","first-page":"G119","DOI":"10.1152\/ajpgi.90274.2008","article-title":"Cannabinoid-1 (CB1) receptors regulate colonic propulsion by acting at motor neurons within the ascending motor pathways in mouse colon","volume":"296","author":"Sibaev","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.bcp.2023.115665_b1235","doi-asserted-by":"crossref","first-page":"8057","DOI":"10.1523\/JNEUROSCI.16-24-08057.1996","article-title":"Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain","volume":"16","author":"Sim","year":"1996","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2023.115665_b1240","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1124\/jpet.102.035618","article-title":"Effect of chronic administration of R-(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212\u20132) or delta(9)-tetrahydrocannabinol on cannabinoid receptor adaptation in mice","volume":"303","author":"Sim-Selley","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.bcp.2023.115665_b1245","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1124\/mol.105.019612","article-title":"Prolonged recovery rate of CB1 receptor adaptation after cessation of long-term cannabinoid administration","volume":"70","author":"Sim-Selley","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2023.115665_b1250","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.bjp.0703050","article-title":"The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)","volume":"129","author":"Smart","year":"2000","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.bcp.2023.115665_b1255","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1124\/mol.114.096495","article-title":"Cannabinoid receptor-interacting protein 1a modulates CB1 receptor signaling and regulation","volume":"87","author":"Smith","year":"2015","journal-title":"Mol Pharmacol"},{"issue":"2-3","key":"10.1016\/j.bcp.2023.115665_b1260","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0014-2999(97)01543-4","article-title":"A role of nitric oxide in WIN 55,212\u20132 tolerance in mice","volume":"343","author":"Spina","year":"1998","journal-title":"Eur J Pharmacol"},{"issue":"6644","key":"10.1016\/j.bcp.2023.115665_b1265","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/42015","article-title":"A second endogenous cannabinoid that modulates long-term potentiation","volume":"388","author":"Stella","year":"1997","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2023.115665_b1270","doi-asserted-by":"crossref","first-page":"G110","DOI":"10.1152\/ajpgi.00148.2003","article-title":"Cannabinoid receptor type 1 modulates excitatory and inhibitory neurotransmission in mouse colon","volume":"286","author":"Storr","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.bcp.2023.115665_b1275","series-title":"Handbook of Experimental PharmacologyCannabinoids","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/3-540-26573-2_11","article-title":"Effects of cannabinoids on neurotransmission","author":"Szabo","year":"2005"},{"issue":"1","key":"10.1016\/j.bcp.2023.115665_b1280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/15563650.2015.1110590","article-title":"A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment","volume":"54","author":"Tait","year":"2016","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.bcp.2023.115665_b1285","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/sj.bjp.0705595","article-title":"G-protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal","volume":"141","author":"Terman","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2023.115665_b1290","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0006-8993(94)91715-9","article-title":"Effects of NMDA receptor blockade and nitric oxide synthase inhibition on the acute and chronic actions of delta 9-tetrahydrocannabinol in mice","volume":"667","author":"Thorat","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.bcp.2023.115665_b1295","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0014-2999(94)90003-5","article-title":"Evidence for a bidirectional cross-tolerance between morphine and delta 9-tetrahydrocannabinol in mice","volume":"260","author":"Thorat","year":"1994","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.bcp.2023.115665_b1300","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1124\/pharmrev.121.000361","article-title":"Sex\/Gender Differences in the Time-Course for the Development of Substance Use Disorder: A Focus on the Telescoping Effect","volume":"75","author":"Towers","year":"2023","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.bcp.2023.115665_b1305","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0006-8993(94)91538-5","article-title":"Inhibition of opiate tolerance by non-competitive N-methyl-D-aspartate receptor antagonists","volume":"633","author":"Trujillo","year":"1994","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.bcp.2023.115665_b1310","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0014-2999(01)01267-5","article-title":"Sex differences in antinociceptive and motoric effects of cannabinoids","volume":"430","author":"Tseng","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bcp.2023.115665_b1315","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bbr.2004.01.029","article-title":"Pharmacokinetic factors in sex differences in Delta 9-tetrahydrocannabinol-induced behavioral effects in rats","volume":"154","author":"Tseng","year":"2004","journal-title":"Behav Brain Res"},{"issue":"2","key":"10.1016\/j.bcp.2023.115665_b1320","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0306-4522(97)00436-3","article-title":"Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system","volume":"83","author":"Tsou","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.bcp.2023.115665_b1325","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1016\/0014-2999(95)00360-W","article-title":"Physical withdrawal in rats tolerant to delta 9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist","volume":"280","author":"Tsou","year":"1995","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.bcp.2023.115665_b1330","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1046\/j.1460-9568.2000.00971.x","article-title":"Cannabinoid withdrawal is dependent upon PKA activation in the cerebellum","volume":"12","author":"Tzavara","year":"2000","journal-title":"Eur J Neurosci"},{"issue":"24","key":"10.1016\/j.bcp.2023.115665_b1335","doi-asserted-by":"crossref","first-page":"9284","DOI":"10.1523\/JNEUROSCI.20-24-09284.2000","article-title":"Cannabinoid withdrawal syndrome is reduced in pre-proenkephalin knock-out mice","volume":"20","author":"Valverde","year":"2000","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.bcp.2023.115665_b1340","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/mp.2016.21","article-title":"Deficits in striatal dopamine release in cannabis dependence","volume":"22","author":"van de Giessen","year":"2017","journal-title":"Mol Psychiatry"},{"issue":"17","key":"10.1016\/j.bcp.2023.115665_b1345","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1038\/sj.emboj.7600784","article-title":"Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels","volume":"24","author":"van der Stelt","year":"2005","journal-title":"EMBO J"},{"issue":"5746","key":"10.1016\/j.bcp.2023.115665_b1350","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1126\/science.1115740","article-title":"Identification and functional characterization of brainstem cannabinoid CB2 receptors","volume":"310","author":"Van Sickle","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.bcp.2023.115665_b1355","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.bbr.2010.07.037","article-title":"Antinociception and sedation following intracerebroventricular administration of Delta(9)-tetrahydrocannabinol in female vs. male rats","volume":"216","author":"Wakley","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bcp.2023.115665_b1360","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.pbb.2014.06.007","article-title":"Cyclic ovarian hormone modulation of supraspinal Delta9-tetrahydrocannabinol-induced antinociception and cannabinoid receptor binding in the female rat","volume":"124","author":"Wakley","year":"2014","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bcp.2023.115665_b1365","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.drugalcdep.2014.07.029","article-title":"Sex differences in antinociceptive tolerance to delta-9-tetrahydrocannabinol in the rat","volume":"143","author":"Wakley","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.bcp.2023.115665_b1370","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/npp.2008.230","article-title":"PKCepsilon regulates behavioral sensitivity, binding and tolerance to the CB1 receptor agonist WIN55,212\u20132","volume":"34","author":"Wallace","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bcp.2023.115665_b1375","doi-asserted-by":"crossref","first-page":"e0140501","DOI":"10.1371\/journal.pone.0140501","article-title":"A Preliminary Investigation of Individual Differences in Subjective Responses to D-Amphetamine, Alcohol, and Delta-9-Tetrahydrocannabinol Using a Within-Subjects Randomized Trial","volume":"10","author":"Wardle","year":"2015","journal-title":"PLoS One"},{"issue":"2651\u20132659","key":"10.1016\/j.bcp.2023.115665_b1380","doi-asserted-by":"crossref","first-page":"e2651","DOI":"10.1016\/j.jid.2022.03.029","article-title":"Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: A Randomized Clinical Trial","volume":"142","author":"Werth","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.bcp.2023.115665_b1385","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1037\/pha0000036","article-title":"Sex differences in associations between cannabis craving and neural responses to cannabis cues: Implications for treatment","volume":"23","author":"Wetherill","year":"2015","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/j.bcp.2023.115665_b1390","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/jama.2015.6358","article-title":"Cannabinoids for Medical Use: A Systematic Review and Meta-analysis","volume":"313","author":"Whiting","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.bcp.2023.115665_b1395","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0376-8716(03)00135-2","article-title":"Functional consequences of the repeated administration of Delta9-tetrahydrocannabinol in the rat","volume":"71","author":"Whitlow","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.bcp.2023.115665_b1400","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neulet.2003.08.050","article-title":"Sex-dependent effects of delta 9-tetrahydrocannabinol on locomotor activity in mice","volume":"352","author":"Wiley","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bcp.2023.115665_b1405","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.110064","article-title":"Sex, species and age: Effects of rodent demographics on the pharmacology of \u0394(9)-tetrahydrocanabinol","volume":"106","author":"Wiley","year":"2021","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bcp.2023.115665_b1410","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1124\/pr.112.005942","article-title":"Regulation of mu-opioid receptors: desensitization, phosphorylation, internalization, and tolerance","volume":"65","author":"Williams","year":"2013","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.bcp.2023.115665_b1415","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109468","article-title":"Cannabimimetic effects of abused indazole-carboxamide synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA and 5F-ADB-PINACA in mice: Tolerance, dependence and withdrawal","volume":"236","author":"Wilson","year":"2022","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.bcp.2023.115665_b1420","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.pbb.2006.07.018","article-title":"SR 141716 (Rimonabant) precipitates withdrawal in marijuana-dependent mice","volume":"85","author":"Wilson","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bcp.2023.115665_b1425","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/35069076","article-title":"Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses","volume":"410","author":"Wilson","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2023.115665_b1430","doi-asserted-by":"crossref","first-page":"e897","DOI":"10.1097\/PR9.0000000000000897","article-title":"Effects of inflammatory pain on CB1 receptor in the midbrain periaqueductal gray","volume":"6","author":"Wilson-Poe","year":"2021","journal-title":"Pain Rep"},{"key":"10.1016\/j.bcp.2023.115665_b1435","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1369-1600.2010.00227.x","article-title":"Long-term behavioral and pharmacodynamic effects of delta-9-tetrahydrocannabinol in female rats depend on ovarian hormone status","volume":"16","author":"Winsauer","year":"2011","journal-title":"Addict Biol"},{"key":"10.1016\/j.bcp.2023.115665_b1440","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.drugalcdep.2012.12.011","article-title":"Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample","volume":"131","author":"Winstock","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.bcp.2023.115665_b1445","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00213-011-2305-5","article-title":"delta(9)-Tetrahydrocannabinol-dependent mice undergoing withdrawal display impaired spatial memory","volume":"217","author":"Wise","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bcp.2023.115665_b1450","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108629","article-title":"Effects of daily Delta(9)-Tetrahydrocannabinol (THC) alone or combined with cannabidiol (CBD) on cognition-based behavior and activity in adolescent nonhuman primates","volume":"221","author":"Withey","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.bcp.2023.115665_b1455","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-3-662-46450-2_7","article-title":"The role of the endocannabinoid system in pain","volume":"227","author":"Woodhams","year":"2015","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.bcp.2023.115665_b1460","doi-asserted-by":"crossref","DOI":"10.1093\/crocol\/otaa089","article-title":"Safety, Pharmacokinetics, and Efficacy of Olorinab, a Peripherally Acting, Highly Selective, Full Agonist of the Cannabinoid Receptor 2, in a Phase 2a Study of Patients With Chronic Abdominal Pain Associated With Crohn's Disease","author":"Yacyshyn","year":"2021","journal-title":"Crohns Colitis"},{"key":"10.1016\/j.bcp.2023.115665_b1465","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1124\/jpet.108.145011","volume":"328","author":"Yao","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2023.115665_b1470","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/sj.bjp.0707568","article-title":"In vitro and in vivo characterization of A-796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain models","volume":"153","author":"Yao","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2023.115665_b1475","doi-asserted-by":"crossref","DOI":"10.1177\/1744806917728227","article-title":"Anti-nociceptive interactions between opioids and a cannabinoid receptor 2 agonist in inflammatory pain","volume":"13","author":"Yuill","year":"2017","journal-title":"Mol Pain"},{"key":"10.1016\/j.bcp.2023.115665_b1480","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/WNR.0000000000000551","article-title":"Tolerance to the antinociceptive and hypothermic effects of morphine is mediated by multiple isoforms of c-Jun N-terminal kinase","volume":"27","author":"Yuill","year":"2016","journal-title":"Neuroreport"},{"key":"10.1016\/j.bcp.2023.115665_b1485","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3892\/etm.2021.10437","article-title":"Molecular mechanisms of opioid tolerance: From opioid receptors to inflammatory mediators (Review)","volume":"22","author":"Zhou","year":"2021","journal-title":"Exp Ther Med"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223002563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223002563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:46:23Z","timestamp":1757771183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295223002563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":297,"alternative-id":["S0006295223002563"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115665","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms of cannabinoid tolerance","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115665","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115665"}}